ImageneBio, Inc. (IMA)
(Real Time Quote from BATS)
$14.44 USD
-0.30 (-2.04%)
Updated Aug 12, 2025 12:22 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IMA 14.44 -0.30(-2.04%)
Will IMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMA
Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to Trade
IMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IMA
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IMA Stock News
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent ...
IMAX: Strong Market Position and Growth Potential Justify Buy Rating
Image Resources NL Updates Director’s Securities Holdings
Imax, Helios partner on two new locations in Poland